SN-CA21

N/A

Report date: 2025/01/26 16:59:19
NME

Base Information

Drug NameSN-CA21
Drug Alias NameCTLA4 inhibitor (Synovel Sciences)CTLA-4 checkpoint inhibitor (Synovel Sciences)SN-CA21
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamerSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynovel Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesFountain Biopharma Inc
Inactive CompaniesSynovel Sciences Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A